The 3D-Hub-O platform was created in 2019 and benefits from the label of Canceropole SUD, which has helped fund the equipment and remuneration of the platform’s engineers. The platform has received the Ibisa label in 2022. 3D-Hub-O specializes in the production, manipulation and analysis of organoids from normal and tumor tissues. It aims to put its expertise at the service of the community, to be a first-rate physiological platform for research on living pathological tissues, and to be committed to improving human health through its contribution to personalized medicine in compliance with current regulations.
3D-Hub-O is located at the Cancer Research Center of Marseille (CRCM) and the Paoli-Calmettes Institute.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 232, Boulevard De Sainte-Marguerite, Marseille,provence-Alpes-Côte D'azur 13009,france
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://3d-hub-organoids.com/
- Keywords
- Marseille.
- HQ
- Marseille, Provence-Alpes-Côte d'Azur
3d-Hub-O Questions
3D-Hub-O's website is https://3d-hub-organoids.com/
3D-Hub-O's LinkedIn profile is https://fr.linkedin.com/company/3d-hub-o
3D-Hub-O has
1 employees.
View email and phone details for 1
employees at 3D-Hub-O.
3D-Hub-O's industry is
Research Services
3D-Hub-O's top competitors are
3d Medlab,
Okomera,
Organoid Technologies,
Zeneuroid,
Hopstem Biotechnology Co., Ltd.,
Tissuse Gmbh,
Biosystics, Inc.,
Nextvivo,
Bullseye Biotechnologies, Inc,
3d Virtual Market.
3D-Hub-O's categories are Research Services
3D-Hub-O's founding year is 2019
